CD8A and neoplasm: Adaptive anti-tumor immunity is principally based on mature dendritic cells (DCs), macrophages, tumor-specific CD4+ T helper 1 cells (Th1), CD8+ cytotoxic T cells (CTLs), and cytotoxic antibody (Ab)-producing B cells.